Danmarks Nationalbank
25.2.2021 12:19:56 CET | Globenewswire | Press release
Bids, sales, stop-rates and prices are presented in the table below:
| ISIN | Bid Mill. kr. (nominal) | Sale | Stop-rate (per cent) | Pro-rata | Price |
| 98 18189 DKT 01/06/21 II | 1,360 | 1,360 | -0.530 | 100 % | 100.1356 |
| 98 18262 DKT 01/09/21 III | 460 | 460 | -0.520 | 100 % | 100.2665 |
| 98 18346 DKT 01/12/21 IV | 1,680 | 1,680 | -0.520 | 100 % | 100.3988 |
| 98 18429 DKT 01/03/22 I | 3,380 | 3,380 | -0.520 | 100 % | 100.5300 |
| Total | 6,880 | 6,880 |
The sale will settle 1 March 2021.
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Alkane Resources Limited30.3.2026 00:16:17 CEST | Press release
Alkane Executes $110 Million Revolving Credit Facility
Fast Ejendom Danmark29.3.2026 18:17:55 CEST | Pressemeddelelse
Aktietilbagekøbsprogram
Newcap Holdings29.3.2026 12:19:20 CEST | Pressemeddelelse
NewCap Holding A/S har indgået en aftale, betinget af underskrivelse af endelige aftaledokumenter m.v., om erhvervelse af dansk selskab indenfor compliance og risikostyringsservices – Intern viden
Novartis Pharma AG29.3.2026 07:15:00 CEST | Press release
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
Biogen Inc.28.3.2026 20:00:00 CET | Press release
Biogen Announces Second Positive Phase 2 Litifilimab Trial in Cutaneous Lupus Erythematosus at 2026 American Academy of Dermatology Annual Meeting, Showing a Significant Reduction in Skin Disease Activity
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom